GlassScriptPhysician profile
Carla Tate
NPI 1033796065
$279.82
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $80.42 | 2023 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $60.20 | 2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $44.39 | 2023 | |
| Novavax INC | $29.47 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Medline Industries LP | $19.14 | 2023 | |
| Merck Sharp & Dohme LLC | $16.24 | 2023 | Verquvo, Belsomra |
| Novartis Pharmaceuticals Corporation | $15.00 | 2023 | |
| Glaxosmithkline, LLC. | $14.96 | 2023 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Tate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.